Clinical management of female patients with Fabry disease based on expert consensus

Eva Brand, Aleš Linhart, Patrick Deegan, et al

Orphanet J Rare Dis. 2025; 20: 7

https://pmc.ncbi.nlm.nih.gov/articles/PMC11707893/

 

Cardiac involvement in Fabry disease: recente advances, unrresolved issues and unmet needs

Maurizio Pieroni, Chiara Zocchi, Michele Ciabatti

Eur Heart J Suppl. 2025 Feb; 27(Suppl 1): i51–i55.

https://pmc.ncbi.nlm.nih.gov/articles/PMC1183671/

 

A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase Beta

Gavin Y. Oudit, Pronabesh DasMahapatra, Nicole Lyn, et al

Front Cardiovasc Med. 2024; 11: 1415547.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11790562/

 

Recommendations for the diagnosis and management of Fabry diseae in pediatric patients: a document from the Rare Diases Committee of the Brazilian Society of Nephrology (Comdora-SBN)

Brazilian Journal of Nefrololgy 2022, vol 44 (2): 268-280

https://www.bjnephrology.org/wp-content/uploads/articles_xml/2175-8239-jbn-2021-0216/2175-8239-jbn-2021-0216-pt.pdf

 

Impact of enzyme replacement therapy and migalastat on disease progression in females with Fabry disease

Malte Lenders, Albina Nowak, Markus Cybulla et al

Orphanet J Rare Dis. 2025; 20: 79.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11843741/

 

Fabry disease and inflammation: potential role of p65 iso5, an isoform of the Nf-kB complex

Giuseppa Biddeci, Gaetano Spinelli, Paolo Colomba et al

Cells. 2025 Feb; 14(3): 230

https://pmc.ncbi.nlm.nih.gov/articles/PMC11817417/

 

Expanded screening for Fabry disease in patients iwth chronic kidney disease not dialysis: a multicenter Italian experience

Yuri Battaglia, Federica Baciga, Meilad Shakkour, et al

Ren Fail. 2025; 47(1): 2454295

https://pmc.ncbi.nlm.nih.gov/articles/PMC11795759/

 

Lentivirus-mediated gene therapy for Fabry Disease: 5-year endo-of-study results form the Canadian FACTs trial

Aneal Khan, Dwayne L. Barber, William M. McKillop, et al

Clin Transl Med. 2025 Jan; 15(1): e70073.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11726700/

 

Prevalence of Fabry disease in patients with chronic pain: lessons from the DOUFAB and DOUFABIS studies

Chloé Angelini, Claire Bar, Marie Pierre Baudier, et al

The DOUFABIS Consortium

Eur J Pain. 2025 Jan; 29(1): e4708

https://pmc.ncbi.nlm.nih.gov/articles/PMC11609957/

 

Dizzines in Fabry Disease

Aslak Broby Johansen, Ulla Feldt-Rasmussen, Mads Klokker

Biomedicines. 2025 Feb; 13(2): 24

https://pmc.ncbi.nlm.nih.gov/articles/PMC11853341/

 

Prevalence and clinical correlates of cerebrovascular alterations in Fabry disease: a cross-sectional study

Daniele Di Natale, Salvatore Rossi, Gianmarco Dalla Zanna et al

Brain Sci. 2025 Feb; 15(2): 166

https://pmc.ncbi.nlm.nih.gov/articles/PMC11852458/

 

Doença de Fabry: Diretrizes Médicas (Fabry Disease: Guidelines)

Arquivos do Blog Internet Médica – agosto 2022

https://internetmedica.com.br/doenca-de-fabry-diretrizes-medicas-fabry-disease-guidelines/

 

Doença de Fabry (Fabry´s Disease)

Arquivos do Blog Internet Médica – agosto 2021

https://internetmedica.com.br/doenca-de-fabry-fabrys-disease/

 

■ Acesso gratuito

■ Um dos Blog de Medicina mais acessado em todo o mundo. Mais de 1450 temas médicos já disponíveis online

■ Use o mecanismo de busca – PESQUISAR na home page.

■ Acesse ARQUIVO e encontre os temas incluídos no Blog a cada mês, desde maio 2017

■ Blog Internet Médica – www.internetmedica.com.br

■ Médico Responsável: Dr Paulo Fernando Leite

CRMMG: 7026

Instagram – https://www.instagram.com/drpaulo.fernando/

Linkedin – https://www.linkedin.com/in/drpaulofernandoleite/

Belo Horizonte/MG/Brasil

Email: pfleite1873@gmail.com

Site: www.drpaulofernandocardio.com.br

Março 2025